Lilly going back to the drawing board, maybe this time we can get a better test?

	Forward to a Friend   December 19, 2012
		Lilly plans additional study of solanezumab for Alzheimer's Eli Lilly & Company has announced it plans additional study of solanezumab, an experimental Alzheimer's drug that previously failed to improve the condition of people with the disease. The company released results of two clinical trials in August that showed the drug did not significantly improve cognition or daily mental function of people with mild and moderate Alzheimer's. However, when the results for people with mild Alzheimer's were separated out, they showed the drug did slow cognitive decline. Read the article >> Learn more about treatments >>   Two sisters embrace the role of caring for their parents Tania Richard was a caregiver for her mother, who was diagnosed with dementia in 2011 and passed away the following year. During her mother's illness, her father was hospitalized with lung cancer. Tania and her sister, Gina, found themselves embracing the challenge of caring for their parents, who were in separate hospitals in different cities. Read the blog post >> Visit our Caregiver Center >>     Birthday girl asks for donations instead of presents Young people may sometimes focus on the gifts they'll receive for their birthday. An 11-year-old Florida girl, whose great-grandmother has Alzheimer's and lives in a nursing home, rejected gifts for her 12th birthday and instead requested donations for senior citizens. Read the article >>   Caregiver resource links Alzheimer's Behaviors >> Caregiver Stress Check >> Comfort Zone® >> Coping with Alzheimer's >> Daily Care >>   Find a Clinical Trial >> Long-Distance Caregiving >> Music, Art and Other Therapies >> Support Groups >> Planning Ahead >> Stop by our brain gym Exercise your brain and test your skills. Solve today's puzzle >> What is Alzheimer's Disease | Know the 10 Signs of Alzheimer's | Brain Tour The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2012 Alzheimer's Association. All rights reserved. www.alz.org |  800.272.3900  To change your email preferences click here.